These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
666 related articles for article (PubMed ID: 22304991)
1. Pretreatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease. Vaughan EE; Liew A; Mashayekhi K; Dockery P; McDermott J; Kealy B; Flynn A; Duffy A; Coleman C; O'Regan A; Barry FP; O'Brien T Cell Transplant; 2012; 21(6):1095-107. PubMed ID: 22304991 [TBL] [Abstract][Full Text] [Related]
2. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization. Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531 [TBL] [Abstract][Full Text] [Related]
3. Derivation of human peripheral blood derived endothelial progenitor cells and the role of osteopontin surface modification and eNOS transfection. Yuan Y; Altalhi WA; Ng JJ; Courtman DW Biomaterials; 2013 Oct; 34(30):7292-301. PubMed ID: 23810253 [TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E positively modulates endothelial progenitor cell homeostasis: an advanced treatment modality for autologous cell therapy. Herrler T; Leicht SF; Huber S; Hermann PC; Schwarz TM; Kopp R; Heeschen C J Vasc Res; 2009; 46(4):333-46. PubMed ID: 19142013 [TBL] [Abstract][Full Text] [Related]
5. Pivotal role of lnk adaptor protein in endothelial progenitor cell biology for vascular regeneration. Kwon SM; Suzuki T; Kawamoto A; Ii M; Eguchi M; Akimaru H; Wada M; Matsumoto T; Masuda H; Nakagawa Y; Nishimura H; Kawai K; Takaki S; Asahara T Circ Res; 2009 Apr; 104(8):969-77. PubMed ID: 19325148 [TBL] [Abstract][Full Text] [Related]
6. Coadministration of endothelial and smooth muscle progenitor cells enhances the efficiency of proangiogenic cell-based therapy. Foubert P; Matrone G; Souttou B; Leré-Déan C; Barateau V; Plouët J; Le Ricousse-Roussanne S; Lévy BI; Silvestre JS; Tobelem G Circ Res; 2008 Sep; 103(7):751-60. PubMed ID: 18723447 [TBL] [Abstract][Full Text] [Related]
7. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia. Finney MR; Greco NJ; Haynesworth SE; Martin JM; Hedrick DP; Swan JZ; Winter DG; Kadereit S; Joseph ME; Fu P; Pompili VJ; Laughlin MJ Biol Blood Marrow Transplant; 2006 May; 12(5):585-93. PubMed ID: 16635794 [TBL] [Abstract][Full Text] [Related]
8. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Yoon CH; Hur J; Park KW; Kim JH; Lee CS; Oh IY; Kim TY; Cho HJ; Kang HJ; Chae IH; Yang HK; Oh BH; Park YB; Kim HS Circulation; 2005 Sep; 112(11):1618-27. PubMed ID: 16145003 [TBL] [Abstract][Full Text] [Related]
9. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia. Ruifrok WP; de Boer RA; Iwakura A; Silver M; Kusano K; Tio RA; Losordo DW Vasc Med; 2009 Feb; 14(1):29-36. PubMed ID: 19144777 [TBL] [Abstract][Full Text] [Related]
10. CD34 hybrid cells promote endothelial colony-forming cell bioactivity and therapeutic potential for ischemic diseases. Lee JH; Lee SH; Yoo SY; Asahara T; Kwon SM Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1622-34. PubMed ID: 23640491 [TBL] [Abstract][Full Text] [Related]
11. β2-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis. Galasso G; De Rosa R; Ciccarelli M; Sorriento D; Del Giudice C; Strisciuglio T; De Biase C; Luciano R; Piccolo R; Pierri A; Di Gioia G; Prevete N; Trimarco B; Piscione F; Iaccarino G Circ Res; 2013 Mar; 112(7):1026-34. PubMed ID: 23418295 [TBL] [Abstract][Full Text] [Related]
12. Efficient nonadhesive ex vivo expansion of early endothelial progenitor cells derived from CD34+ human cord blood fraction for effective therapeutic vascularization. O E; Lee BH; Ahn HY; Shin JC; Kim HK; Kim M; Park IY; Park YG; Joe YA FASEB J; 2011 Jan; 25(1):159-69. PubMed ID: 20852063 [TBL] [Abstract][Full Text] [Related]
13. In vivo enhancement of angiogenesis by adenoviral transfer of HIF-1alpha-modified endothelial progenitor cells (Ad-HIF-1alpha-modified EPC for angiogenesis). Jiang M; Wang B; Wang C; He B; Fan H; Shao Q; Gao L; Liu Y; Yan G; Pu J Int J Biochem Cell Biol; 2008; 40(10):2284-95. PubMed ID: 18450499 [TBL] [Abstract][Full Text] [Related]
14. Augmented neovascularization with magnetized endothelial progenitor cells in rats with hind-limb ischemia. Koiwaya H; Sasaki K; Ueno T; Yokoyama S; Toyama Y; Ohtsuka M; Nakayoshi T; Mitsutake Y; Imaizumi T J Mol Cell Cardiol; 2011 Jul; 51(1):33-40. PubMed ID: 21447346 [TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-δ activates endothelial progenitor cells to induce angio-myogenesis through matrix metallo-proteinase-9-mediated insulin-like growth factor-1 paracrine networks. Han JK; Kim HL; Jeon KH; Choi YE; Lee HS; Kwon YW; Jang JJ; Cho HJ; Kang HJ; Oh BH; Park YB; Kim HS Eur Heart J; 2013 Jun; 34(23):1755-65. PubMed ID: 21920965 [TBL] [Abstract][Full Text] [Related]
16. Akt is a key modulator of endothelial progenitor cell trafficking in ischemic muscle. Hur J; Yoon CH; Lee CS; Kim TY; Oh IY; Park KW; Kim JH; Lee HS; Kang HJ; Chae IH; Oh BH; Park YB; Kim HS Stem Cells; 2007 Jul; 25(7):1769-78. PubMed ID: 17412896 [TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway. Han JK; Lee HS; Yang HM; Hur J; Jun SI; Kim JY; Cho CH; Koh GY; Peters JM; Park KW; Cho HJ; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS Circulation; 2008 Sep; 118(10):1021-33. PubMed ID: 18711014 [TBL] [Abstract][Full Text] [Related]
18. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Urbich C; Heeschen C; Aicher A; Dernbach E; Zeiher AM; Dimmeler S Circulation; 2003 Nov; 108(20):2511-6. PubMed ID: 14581410 [TBL] [Abstract][Full Text] [Related]
19. Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Hamada H; Kim MK; Iwakura A; Ii M; Thorne T; Qin G; Asai J; Tsutsumi Y; Sekiguchi H; Silver M; Wecker A; Bord E; Zhu Y; Kishore R; Losordo DW Circulation; 2006 Nov; 114(21):2261-70. PubMed ID: 17088460 [TBL] [Abstract][Full Text] [Related]
20. A novel stem cell source for vasculogenesis in ischemia: subfraction of side population cells from dental pulp. Iohara K; Zheng L; Wake H; Ito M; Nabekura J; Wakita H; Nakamura H; Into T; Matsushita K; Nakashima M Stem Cells; 2008 Sep; 26(9):2408-18. PubMed ID: 18583536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]